Biohit Oyj
Develops diagnostic products for early disease detection, focusing on gastroenterology.
BIOBV | HE
Overview
Corporate Details
- ISIN(s):
- FI0009005482
- LEI:
- 74370089ATTSNBXJVT29
- Country:
- Finland
- Address:
- LAIPPATIE 1, FI-00880 HELSINKI
- Sector:
- Manufacturing
Description
Biohit Oyj is a global biotechnology company that develops, manufactures, and markets innovative diagnostic products and services. The company specializes in tools for the early diagnosis and prevention of diseases, with a primary focus on gastroenterology. Its key offerings include the GastroPanel® blood test for assessing stomach health and screening for risks of gastric cancer, as well as diagnostic tests for conditions such as Helicobacter pylori infection. Operating under the mission "Innovating for Health," Biohit's products are designed to support medical research, facilitate early and accurate diagnosis, and improve patient quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2016-02-12 07:30 |
Biohit Oyj’s new B-shares have been registered with the Trade Register as a par…
|
Finnish | HTML • 3.1 KB | ||
| 2016-02-12 07:30 |
Biohit Oyj’s new B-shares have been registered with the Trade Register as a par…
|
English | HTML • 3.1 KB | ||
| 2016-01-22 14:00 |
Genetic Analysis AS general meeting has approved the share exchange with Biohit…
|
Finnish | HTML • 2.3 KB | ||
| 2016-01-22 14:00 |
Genetic Analysis AS general meeting has approved the share exchange with Biohit…
|
English | HTML • 2.3 KB | ||
| 2016-01-05 13:30 |
Biohit Oyj buys a share of Norwegian Genetic Analysis AS company with a directe…
|
Finnish | PDF • 541.0 KB | ||
| 2016-01-05 13:30 |
Biohit Oyj buys a share of Norwegian Genetic Analysis AS company with a directe…
|
English | PDF • 616.8 KB | ||
| 2015-12-17 13:30 |
Biohit Oyj will change its financial reporting – in the future, the company wil…
|
Finnish | HTML • 2.0 KB | ||
| 2015-12-17 13:30 |
Biohit Oyj will change its financial reporting – in the future, the company wil…
|
English | HTML • 2.1 KB | ||
| 2015-12-16 13:30 |
Biohit Oyj’s Management Team Option Arrangement
|
Finnish | HTML • 1.5 KB | ||
| 2015-12-16 13:30 |
Biohit Oyj’s Management Team Option Arrangement
|
English | HTML • 1.6 KB | ||
| 2015-12-04 09:15 |
KORJAUS: Biohitin taloudellinen tiedottaminen ja yhtiökokous vuonna 2016
|
Finnish | HTML • 2.0 KB | ||
| 2015-12-04 07:30 |
Biohit's Financial Reporting and Annual General Meeting in 2016
|
Finnish | HTML • 1.9 KB | ||
| 2015-12-04 07:30 |
Biohit's Financial Reporting and Annual General Meeting in 2016
|
English | HTML • 2.0 KB | ||
| 2015-11-04 08:30 |
Acetium imeskelytabletti - lupaava uusi menetelmä avuksi tupakoinnin lopettamis…
|
Finnish | HTML • 5.7 KB | ||
| 2015-11-04 08:30 |
Acetium lozenge – a promising novel method to assist smoking cessation
|
English | HTML • 5.5 KB |
Automate Your Workflow. Get a real-time feed of all Biohit Oyj filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Biohit Oyj
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Biohit Oyj via our API.
Peer Companies
